Drug watch.
- Published in:
- 2008
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2008 AND VI 43 AND IP 4
Results: 20
1
2
Safety labeling updates & new warnings.
- Published in:
- 2008
- Publication type:
- Journal Article
3
Process steps and suggestions for creating drug monographs and drug class reviews in an evidence-based formulary system.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
4
DPP-IV inhibitors: a review of sitagliptin, vildagliptin, alogliptin, and saxagliptin.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
5
First-time generic approvals.
- Published in:
- 2008
- Publication type:
- Journal Article
6
Integrating recent growth factor evidence, practice guidelines, and FDA recommendations: validating the pharmacist's role in management.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
7
FDA actions in brief.
- Published in:
- 2008
- Publication type:
- Journal Article
8
New molecular entity.
- Published in:
- 2008
- Publication type:
- Journal Article
9
Drug Watch.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 148
- Publication type:
- Article
10
EPITHET: Patients who suffer a stroke and have a perfusion-diffusion mismatch may benefit from tPA beyond the 3-hour window.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 147
- Publication type:
- Article
11
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 146
- Publication type:
- Article
12
Off-label stent use: DES associated with equal safety risks and reduced risk of repeat PCI compared with BMS.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 146
- Publication type:
- Article
13
Process steps and suggestions for creating drug monographs and drug class reviews in an evidence-based formulary system.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 135
- By:
- Publication type:
- Article
14
Integrating Recent Growth Factor Evidence, Practice Guidelines, and FDA Recommendations: Validating the Pharmacist's Role in Management.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 1
- Publication type:
- Article
15
DPP-IV inhibitors: A review of sitagliptin, vildagliptin, alogliptin, and saxagliptin.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 122
- By:
- Publication type:
- Article
16
First-time generic approvals.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 121
- Publication type:
- Article
17
FDA actions in brief.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 121
- Publication type:
- Article
18
New biologic.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 120
- Publication type:
- Article
19
New molecular entity.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 120
- Publication type:
- Article
20
Pipeline preview.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 120
- Publication type:
- Article